Immusoft

Pre-clinical

Seattle, United StatesFounded 1986immusoft.com

Immusoft is the world leader in the development of B cells as biofactories for therapeutic protein delivery, a novel approach that we have pioneered. Our approach, called Immune System Programming (ISP™) entails collecting a type of the patient’s immune cells, called B cells. In response...

Founded

1986

Focus

Cell & Gene Therapy

About

Immusoft is the world leader in the development of B cells as biofactories for therapeutic protein delivery, a novel approach that we have pioneered. Our approach, called Immune System Programming (ISP™) entails collecting a type of the patient’s immune cells, called B cells. In response...

Funding History

2

Total raised: $47M

Series A$42MVulcan CapitalOct 15, 2023

Seed$5MAlexandria Venture InvestmentsJun 15, 2021

Company Info

TypePrivate

Founded1986

LocationSeattle, United States

StagePre-clinical

Contact

Sectors

Cell & Gene Therapy

SIMILAR COMPANIES

BASi Research Products

Pre-clinical · West Lafayette

Bay BioSciences

Pre-clinical · San Francisco

Pre-clinical · Cambridge

Pre-clinical · Memphis

Belcher Pharmaceuticals

Pre-clinical · Miami

Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.